Organovo's Drug Significantly Reduces Liver Fat in NASH Study Organovo's Drug Significantly Reduces Liver Fat in NASH Study
Organovo Holdings ' experimental drug reduced liver fat by as much as 22.8% in a mid-stage study of some patients with non-alcoholic steatohepatitis (NASH), fueling optimism...Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - April 15, 2024 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
SIR publishes statement regarding pediatric trauma care
The Society of Interventional Radiology (SIR) has released a position statement that outlines best practices for image-guided endovascular interventions when treating children in emergency situations.
The statement was published April 15 in the Journal of Vascular and Interventional Radiology. It was written by a team of pediatric trauma experts representing interventional radiology, emergency medicine, intensive care medicine, and surgery; the team performed a literature review to establish 15 recommendations for traumatic injuries to the liver, spleen, kidneys, abdomen, pelvis, vascular system, and the extremities.
The...
Source: AuntMinnie.com Headlines - April 15, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Mayo Clinic Minute: Reasons to be a living kidney donor
Nearly 90,000 people in the U.S. are on the waiting list for kidney transplant, according to the Organ Procurement and Transplantation Network. Finding a donor kidney that is compatible and matches the right blood and tissue types can be the biggest challenge, especially when the donor pool isn't as large as the number of people who need a transplant. Dr. Naim Issa, a Mayo Clinic transplant nephrologist, says there are some common myths regarding living… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 15, 2024 Category: Databases & Libraries Source Type: news
Know the signs of irritable bowel syndrome
April is IBS Awareness Month, which makes this a good time to learn about the symptoms of irritable bowel syndrome, or IBS. Research suggests that about 12% of people in the U.S. have irritable bowel syndrome, and it's more common among women than men and in people younger than 50, according to the National Institute of Diabetes and Digestive and Kidney Diseases. Irritable bowel syndrome is a chronic condition that affects the large intestine. Even though the digestive… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 14, 2024 Category: Databases & Libraries Source Type: news
Houston hospital says doctor's changes to a database made patients ineligible for liver transplants
A Houston hospital has halted its liver and kidney transplant programs after it says a doctor manipulated a database for liver transplant patients, making them ineligible to receive a new organ (Source: ABC News: Health)
Source: ABC News: Health - April 12, 2024 Category: Consumer Health News Tags: Health Source Type: news
Improving diagnosis of a dangerous but overlooked disease of pregnancy
A new grant will fund Yale research into improving diagnostic techniques for a rare liver condition found in pregnant women that can cause fetal complications. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 12, 2024 Category: Universities & Medical Training Source Type: news
Houston hospital halts liver and kidney transplants after learning a doctor manipulated some records
Memorial Hermann-Texas Medical Center in Houston has halted its liver transplant and kidney transplant programs (Source: ABC News: Health)
Source: ABC News: Health - April 12, 2024 Category: Consumer Health News Tags: Health Source Type: news
Radiologists experience modest pay increase
Radiologists have again jumped up a spot in earnings among the top 10 specialists in the U.S., according to a Medscape survey.
The average income for radiologists was $498,000, up 3% from last year’s average of $483,000, according to Medscape's 2024 Physician Compensation Report, released April 12. This places radiology up one spot over last year to sixth on the list of the top 10 earning specialties.
The findings are from survey responses from 7,000 physicians across more than 29 specialties between October 2023 and January 2024.
Above radiology in the highest-compensated specialties were orthopedics, plastic surgery...
Source: AuntMinnie.com Headlines - April 12, 2024 Category: Radiology Authors: Will Morton Tags: Industry News Economics Source Type: news
What to know about the new EPA rule limiting'forever chemicals' in tap water
Wednesday the Environmental Protection Agency announced new drinking water standards to limit people's exposure to some PFAS chemicals. For decades, PFAS have been used to waterproof and stain-proof a variety of consumer products. These "forever chemicals" in a host of products — everything from raincoats and the Teflon of nonstick pans to makeup to furniture and firefighting foam. Because PFAS take a very long time to break down, they can accumulate in humans and the environment. Now, a growing body of research is linking them to human health problems like serious illness, some cancers, lower fertility and liver damage....
Source: NPR Health and Science - April 12, 2024 Category: Consumer Health News Authors: Pien Huang Source Type: news
Texas Surgeon Is Accused of Secretly Denying Liver Transplants
A Houston hospital is investigating whether a doctor altered a transplant list to make his patients ineligible for care. A disproportionate number of them have died while waiting for new organs. (Source: NYT Health)
Source: NYT Health - April 11, 2024 Category: Consumer Health News Authors: Brian M. Rosenthal and Jessica Silver-Greenberg Tags: Kidneys Liver Doctors Transplants Hospitals Memorial Hermann Houston (Tex) Texas United States Source Type: news
Midlife Deaths of Despair Increased From 1999 to 2022
THURSDAY, April 11, 2024 -- Midlife deaths from suicide, drug overdose, and alcoholic liver disease, collectively known as deaths of despair, increased from 1999 through 2022, according to a research letter published online April 10 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 11, 2024 Category: Pharmaceuticals Source Type: news
Cochrane International Mobility - Yu-Tian Xiao
Cochrane ' s members and supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, people passionate about improving health outcomes for everyone, everywhere.Getting involved in Cochrane ’s work means becoming part of a global community.The Cochrane International Mobility programmeconnects successful applicants with a placement in a host Cochrane Group, where they learn about the production, use, and knowledge translation of Cochrane reviews. The prgramme offers opportunities for learning and training not only for participants but als...
Source: Cochrane News and Events - April 11, 2024 Category: Information Technology Authors: Muriah Umoquit Source Type: news
Metabolite in Red Meat Increases Kidney Disease Risk Metabolite in Red Meat Increases Kidney Disease Risk
Trimethylamine N-oxide could be a novel risk factor and intervention target for chronic kidney disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 11, 2024 Category: Consumer Health News Tags: Nephrology Clinical Summary Source Type: news
Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune Why Alpine Immune Sciences Stock …
On Wednesday, Vertex Pharmaceuticals Incorporated VRTX agreed to acquire Alpine Immune Sciences Inc ALPN for $65 per share or approximately $4.9 billion in cash. Alpine’s lead molecule, povetacicept (ALPN-303), is a highly potent and effective dual antagonist of BAFF (B cell activating factor) and…#baff #phase2 #phase3 #vertex #proteinuria #hematuria #alpine #alpn (Source: Reuters: Health)
Source: Reuters: Health - April 11, 2024 Category: Consumer Health News Source Type: news
Boston company to buy Alpine Immune Sciences for $4.9B
The Seattle biotech is developing a drug to treat kidney disease. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 11, 2024 Category: Biotechnology Authors: Don Seiffert Source Type: news
